Found: 4
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 77–85
Kudryashov G.G., Vinogradova T.I., Zmitrichenko Yu.G., Krylova Yu.S., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Agafonov G.M., Yablonskiy P.K.
Aim of the study. The possibility of using antitumor drugs against the background of active tuberculosis is an unresolved problem of modern medicine. The aim of the experimental study was to study the course of tuberculosis infection against the background of …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 45–52
Sinyavskaya A.M., Troitskii A.V., Bystrova T.N., Novikova E.G., Selyatitskaya V.G.
Introduction. An actual decision of the issue of safety and effective drug therapy improvement is the development of transport systems that allow to provide targeted delivery of drugs to target cells, while reducing their toxic effects. The aim of the work was…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42
Kudriashov G.G., Zmitrichenko Yu.G., Vinogradova T.I., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Krylova Yu.S., Yablonskii P.K.
Introduction. Treatment of the coexistent pathology of lung cancer and tuberculosis remains the prerogative of experimental research, since the optimal treatment strategy for the coexistence of these two diseases has not yet been developed. The purpose was to …
ОБЗОР2018
Snalina N.E., Sychev D.A.
Currently, tuberculosis is the second leading cause of death from an infectious agent in the world and an important social and medical-biological problem. The first-line drug isoniazid is one of the most effective antituberculosisdrug, however it has a wide sp…